Waterford, CT, United States of America

Banauara L Mylari

This inventor holds 2 USPTO granted patents. Top assignee: Pfizer Corporation. Active years: 2001-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Banauara L Mylari. Retrieved from https://idiyas.com/inventor/banauara-l-mylari

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2001-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Banauara L Mylari

Introduction

Banauara L Mylari is a notable inventor based in Waterford, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have potential therapeutic applications.

Latest Patents

Mylari holds 2 patents that focus on bisamidine compounds. His latest patents include "Indolyl-2-phenyl bisamidines useful as antiproliferative agents" and "Bisamidine compounds as antiproliferative agents." These compounds have been discovered to possess DNA methyltransferase inhibiting properties, making them valuable for preparing pharmaceutical compositions aimed at treating diseases characterized by abnormally rapid tissue proliferation.

Career Highlights

Banauara L Mylari is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to contribute to innovative research and development in the pharmaceutical industry.

Collaborations

Mylari has collaborated with esteemed colleagues such as Steven Wayne Goldstein and Jose R Perez. These collaborations have further enhanced the impact of his research and innovations.

Conclusion

Banauara L Mylari's work exemplifies the importance of innovation in the pharmaceutical field. His contributions through patents and collaborations continue to advance the development of new therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…